title: SEOM clinical guidelines in metastatic breast cancer 2015.
abstract: Metastatic breast cancer is essentially an incurable disease. However, recent advances have resulted in a significant improvement of overall survival. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with metastatic breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference.
authors.affiliation: Servicio de Oncología Médica, Fundación Instituto Valenciano de Oncología, Valencia, Spain. jogagre@hotmail.com.
authors.forename: J
authors.initials: J
authors.lastname: Gavilá
authors.affiliation: Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Lopez-Tarruella
authors.affiliation: Servicio de Oncología Médica, Hospital Vall d' Hebron, Barcelona, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Saura
authors.affiliation: Servicio de Oncología Médica, Hospital Clinic I Provincial, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Muñoz
authors.affiliation: Servicio de Oncología Médica, Hospital Vall d' Hebron, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Oliveira
authors.affiliation: Servicio de Oncología Médica, Complejo Hospitalario Regional Virgen Macarena, Seville, Spain.
authors.forename: L
authors.initials: L
authors.lastname: De la Cruz-Merino
authors.affiliation: Servicio de Oncología Médica, Hospital Universitari Arnau de Villanova de Lleida, Lleida, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Morales
authors.affiliation: Servicio de Oncología Médica, Hospital Donostia-Donostia Ospitalea, Donostia, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Alvarez
authors.affiliation: Servicio de Oncología Médica, Complejo Hospitalario Regional Virgen Macarena, Seville, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: Virizuela
authors.affiliation: Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Martin
mesh_terms: D001943:Breast Neoplasms / Q000556:secondary* / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008495:Medical Oncology; D008875:Middle Aged; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic / Q000592:standards*; D011379:Prognosis; D012955:Societies, Medical
keywords: Anti-HER2 therapy; Chemotherapy; Clinical guidelines; Hormonal therapy; Metastatic breast cancer